|
|
You are searching for "CFAMM00307103" in compound. Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
CFAM Mol ID | CFAMM00307103 |
Family | CFFBM94 Pol polyprotein inhibitor tert-butyl N-[(2S,3S,5R)-3-hydroxy-6-[[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-[(4-methylphenyl)methyl]-6-oxo-1-phenylhexan-2-yl]carbamate family |
Superfamily | CFSBM64 Pol polyprotein and Disintegrin Binder Superfamily |
Class | CFCBM26 Class 3076 |
External ID | CHEMBL320150 |
External Source | CHEMBL |
PubChem CID |
44333339 |
Functional Category |
Bioactive |
Molecule Name |
tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-6-[[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-methyl-6-oxo-1-phenylhexan-2-yl]carbamate |
IUPAC Name |
tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-6-[[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-methyl-6-oxo-1-phenylhexan-2-yl]carbamate |
Synonyms |
|
InChi |
InChI=1S/C34H42N2O5/c1-33(2,3)41-32(40)35-27(19-23-13-7-5-8-14-23)29(38)22-34(4,21-24-15-9-6-10-16-24)31(39)36-30-26-18-12-11-17-25(26)20-28(30)37/h5-18,27-30,37-38H,19-22H2,1-4H3,(H,35,40)(H,36,39)/t27-,28+,29-,30+,34+/m0/s1 |
InChiKey |
DMZUPOFDIRSBAO-VMJOLXKWSA-N |
Formula | C34H42N2O5 |
Molecular Weight | 558.71 |
Cross Link | CHEMBL320150 |
Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes. |
How to cite our database |
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
2014.08.29
|
48716 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|